GB0139

Galecto slashes workforce, explores options after failed fibrosis trial

Galecto slashes workforce, explores options after failed fibrosis trial

Anika Sharma

Boston-based biotech firm Galecto is facing a significant workforce reduction of 70%, affecting 29 employees, following the discontinuation of its ...